Dietary intervention to reduce symptoms of long COVID

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of a Whole-Diet Approach over 16 weeks to alleviate symptoms of Post-Acute COVID-19 Syndrome (PACS) in adults aged 50 and older. Participants will be randomly assigned to either a Dietary Intervention Group, receiving personalized dietary plans and weekly sessions with a Registered Dietitian, or an Attention Control Group, attending general health education sessions without specific dietary guidance. The primary focus is on reducing fatigue and improving muscle function through a diet rich in anti-inflammatory properties. The study aims to provide insights into dietary impacts on long COVID symptoms.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age of 50 years or older
2. No known active infectious disease (COVID-19 or other).
3. Participant diagnosed with long-COVID/ post- acute COVID-19 syndrome (PACS) /ICD-10-CM codes U09.9
4. Moderate/severe fatigue Brief Fatigue Inventory (BFI)≥4
5. Poor diet quality assessed by the short Healthy Eating Index (HEI)\<70

Exclusion Criteria:

1. Participants with a home oxygen requirement or requiring chronic ventilator support
2. Participants diagnosed with diabetes who do not have a recent HbA1c level or with HbA1c \> 9%
3. Participants diagnosed with Congestive Heart Failure (CHF New York Heart Association) \> class 2
4. Participants with dietary restrictions due to medication use that affects blood clotting, such as Warfarin or other reasons.
5. Evidence of any condition as determined by a physician or the study team that would lead to an increased risk of illness due to any aspect of proposed testing and interventions, or introduce unanticipated confounding of study results.
6. Participants diagnosed with uncontrolled hypertension that will be defined as:

   1. Systolic blood pressure consistently equal to or higher than 190 mmHg.
   2. Diastolic blood pressure consistently equal to or higher than 110 mmHg.
   3. Participants with a recent history of hypertensive crisis (severe elevation in blood pressure requiring immediate medical intervention), regardless of current blood pressure levels.
7. Participants with diet restrictions or allergies that can affect adherence to the diet, such as allergy to fish or shellfish.
8. Participation in another trial in which active intervention is being received.
9. Participants with active drug or alcohol use/dependence that would interfere with adherence to the study.
10. Participants scheduled for surgical procedures within the next 6 months.
11. Participants diagnosed with active cancer.
12. Participants diagnosed with liver diseases.
13. Participants diagnosed with kidney-related conditions, including Chronic Kidney Disease (CKD) \> stage 3.
14. Below the age of 50 years.

Where it's running

• University of Maryland, Baltimore
  Baltimore, Maryland, United States Recruiting

Study contacts

• Study coordinator: Galya Bigman, PhD
• Email: gbigman@som.umaryland.edu
• Phone: 4109168191

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Remote Ischaemic Conditioning for Fatigue After Stroke 2

  Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.

  Recruiting Phase 2 Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield, South Yorkshire · NCT07914647

• Micro-choice-based approach to fatigue management

  A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT07726082

• HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults

  This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.

  Recruiting at 29 sites Phase 3 Harmony Biosciences Management, Inc. · Birmingham, Alabama and 52 other locations · NCT07675135

• See if Nuvastatic helps with cancer-related fatigue in colon cancer patients on first-line chemotherapy

  This trial tests whether Nuvastatic can lessen fatigue in adults with colon cancer who are receiving their first round of chemotherapy, compared to placebo.

  Recruiting at 6 sites Phase 3 Natureceuticals Sdn Bhd · Srikakulam, Andhra Pradesh and 5 other locations · NCT07669519

• Balance and gait in multiple sclerosis: linking motion data to function

  Researchers will see if precise motion measurements of balance and walking relate to everyday functional tests in adults with MS.

  Recruiting at 2 sites University of Patras · Ioannina and 1 other locations · NCT07630311

• Relaxation and breathing techniques to help with breathlessness and tiredness in cancer patients in palliative care

  This study tests whether progressive muscle relaxation or deep breathing exercises can reduce dyspnea and fatigue and improve self-care in adults with cancer receiving palliative care.

  Recruiting at 4 sites Ankara University · Ankara, YENIMAHALLE and 3 other locations · NCT07619209

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.